AbbVie Inc. — Director's Dealing 2016

Sep 27, 2016

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: REATA PHARMACEUTICALS INC (RETA)
CIK: 0001358762
Period of Report: 2016-09-23

Reporting Person: AbbVie Inc. (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Class A Common Stock	135232	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Class B Common Stock	$		Class A Common Stock (1505241)		Direct

Footnotes

F1: The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time after November 22, 2016. The conversion right of the Class B common stock has no expiration date.